Clinical trial
Autologous/Allogeneic Progenitor Stem Cell Therapy for Congestive Heart Failure
NCT00128258 · Amit, Patel N, M.D., Other · Terminated
Key facts
| NCT number | NCT00128258 |
|---|---|
| Title | Autologous/Allogeneic Progenitor Stem Cell Therapy for Congestive Heart Failure |
| Official title | Phase 1 Study: Autologous/Allogeneic Bone Marrow Progenitor Cell Treatment for Heart Failure |
| Lead sponsor | Amit, Patel N, M.D., Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Biological, Procedure |
| Interventions | Injection of bone marrow cells in the heart, Biological bone marrow cell therapy |
| Enrollment | 10 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2016 |
| Completion | Dec 1, 2016 |
| First posted | Aug 9, 2005 |
| Last update posted | Jan 19, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: